SINCALIDE
NDC 63323-579, sincalide, injection, powder, lyophilized, for solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-579
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA017697
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-579 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SINCALIDE5 ug/5mL
Pharmacologic classes
Cholecystokinin Analog [EPC]; Cholecystokinin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-579-05 | 63323057905 | 10 VIAL in 1 PACKAGE (63323-579-05) / 5 mL in 1 VIAL (63323-579-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bb5057da-8568-49b9-947d-fab7d8d8f257Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-579
Use it
Look up 63323-579 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-579 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-579. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.